15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Constellium Nv, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $28.00 to $39.00, so the covering firms are broadly aligned. The average target of $33.20 sits 22% above the current $27.15. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.45 next quarter toward $2.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Constellium Nv.
As of Sep, 4 of 5 firms rate CSTM a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CSTM EPS & revenue forecast
EPS · NEXT QUARTER
$0.45
Range $0.40 – $0.48 · 3 analysts · -34% YoY
Next period, 3 analysts expect Constellium Nv to earn $0.45 a share (range $0.40 – $0.48), versus $0.68 a year earlier. Full-year consensus is $3.66, growing to $2.41 the year after.
REVENUE · NEXT QUARTER
$2.2B
Range $2.1B – $2.3B · 3 analysts · +20% YoY
Revenue is expected to reach $2.2B (range $2.1B – $2.3B), +19.6% year-over-year. Full-year consensus is $9.0B, rising to $9.1B next year.
Top analysts covering Constellium Nv
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CSTM.
#1
Bill Peterson
JP Morgan · Rank #224
Hold
$34.00+25.2% to target
Overall win rate
40%
+ Follow
#2
Timna Tanners
Wells Fargo
Buy
$39.00+43.6% to target
Coverage
—
+ Follow
#3
KJ
Katja Jancic
BMO Capital
Buy
$37.00+36.3% to target
Coverage
—
+ Follow
#4
AS
Alex Stansbury
UBS
Buy
$35.00+28.9% to target
Coverage
—
+ Follow
#5
Corinne Blanchard
Deutsche Bank
Buy
$28.00+3.1% to target
Coverage
—
+ Follow
CSTM stock forecast FAQ
What is CSTM's average 12-month price target?+
The 5 analysts with a live target average $33.20 for Constellium Nv over the next 12 months, ranging from a $39.00 high to a $28.00 low.
Is CSTM stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CSTM?+
The Street-high target is $39.00 (Wells Fargo), and the Street-low is $28.00 (Deutsche Bank). The average of all 5 active targets is $33.20.
How many Wall Street analysts cover CSTM?+
5 analysts have an active rating on Constellium Nv, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering CSTM?+
Among analysts who currently cover CSTM, Bill Peterson of JP Morgan has the strongest overall Quantellect track record (Rank #224). Their current call is Hold with a $34.00 target.
What is Constellium Nv's projected EPS for next quarter?+
The consensus estimate is $0.45 per share (range $0.40 – $0.48) across 3 analysts. Full-year EPS is projected at $3.66, rising to $2.41 the following year.
How much revenue is Constellium Nv expected to report next quarter?+
Consensus revenue is $2.2B (range $2.1B – $2.3B). Full-year revenue is projected at $9.0B, growing to $9.1B next year.
Have analysts been upgrading or downgrading CSTM lately?+
As of Sep, 4 of 5 firms rate CSTM a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CSTM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.